Literature DB >> 9496822

Herpes simplex encephalitis (HSE) and the immunocompromised: a clinical and autopsy study of HSE in the settings of cancer and human immunodeficiency virus-type 1 infection.

D Schiff1, M K Rosenblum.   

Abstract

Although herpes simplex encephalitis (HSE) is not regarded as an opportunistic infection, the occurrence of HSE in immunocompromised patients has been documented and the suggestion made that unusual clinical and neuropathologic features characterize the disorder in this population. To further characterize HSE as it affects the immunodeficient, the authors reviewed the clinical and pathological findings in three immunocompromised patients with autopsy-proven HSE. Two patients had cancer (one with lymphoma and another with glioblastoma multiforme), one was known to be human immunodeficiency virus-type 1 (HIV-1)-seropositive and a second was suspected of harboring underlying HIV-1 infection. Two were receiving dexamethasone at onset of HSE. All had fever, mental status changes and new, focal neurological deficits or worsening of established deficits. Cerebrospinal fluid (CSF) pleocytosis was absent or minimal and head computerized tomographic (CT) scans, performed in all cases, were unrevealing. No patient was clinically suspected of having HSE, only one received acyclovir (for concurrent mucocutaneous herpes) and HSE played a major role in all deaths. Autopsy revealed an unusual form of HSE characterized by a noninflammatory, pseudoischemic histological presentation and the unexpected persistence of viral antigens in abundance despite survival beyond the clinical stage during which inflammatory responses usually peak and productive brain infection wanes. The incidence of HSE in the immunocompromised may be underestimated. Preexistent neurological disease, a noninflammatory CSF profile and negative CT scan may confound the diagnosis in this population, a typical clinical presentation notwithstanding. Increased clinical suspicion, the use of magnetic resonance imaging and polymerase chain reaction analysis of CSF for herpes simplex virus nucleic acid sequences may permit more rapid diagnosis and treatment. The absence of inflammatory infiltrates in some fatal cases of HSE suggests that an intact immune response is not requisite to the devastating neurological injury characteristic of this disorder.

Entities:  

Mesh:

Year:  1998        PMID: 9496822     DOI: 10.1016/s0046-8177(98)90038-7

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  21 in total

1.  Experimental herpes simplex virus encephalitis: a combination therapy of acyclovir and glucocorticoids reduces long-term magnetic resonance imaging abnormalities.

Authors:  Uta K Meyding-Lamadé; Christoph Oberlinner; Philipp R Rau; Sonja Seyfer; Sabine Heiland; Johann Sellner; Brigitte T Wildemann; Wolfram R Lamadé
Journal:  J Neurovirol       Date:  2003-02       Impact factor: 2.643

2.  Herpes simplex encephalitis in patients with cancer.

Authors:  Jerome J Graber; Marc K Rosenblum; Lisa M DeAngelis
Journal:  J Neurooncol       Date:  2011-06-03       Impact factor: 4.130

Review 3.  Herpes Simplex Virus-1 Encephalitis in Adults: Pathophysiology, Diagnosis, and Management.

Authors:  Michael J Bradshaw; Arun Venkatesan
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

4.  Atypical manifestations and poor outcome of herpes simplex encephalitis in the immunocompromised.

Authors:  Ik L Tan; Justin C McArthur; Arun Venkatesan; Avindra Nath
Journal:  Neurology       Date:  2012-11-07       Impact factor: 9.910

5.  Herpes simplex encephalitis in an immunocompromised adult with novel MRI and pathology findings.

Authors:  Janhavi Modak; Xianyuan Song; Pasquale Finelli; Avinash Prasad
Journal:  Clin Neuroradiol       Date:  2016-08-24       Impact factor: 3.649

Review 6.  Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential.

Authors:  Mark L Hanke; Tammy Kielian
Journal:  Clin Sci (Lond)       Date:  2011-11       Impact factor: 6.124

7.  Herpesvirus infections of the central nervous system in immunocompromised patients.

Authors:  Uta Meyding-Lamadé; Cornelia Strank
Journal:  Ther Adv Neurol Disord       Date:  2012-09       Impact factor: 6.570

Review 8.  Immunomodulatory Strategies in Herpes Simplex Virus Encephalitis.

Authors:  Jocelyne Piret; Guy Boivin
Journal:  Clin Microbiol Rev       Date:  2020-02-12       Impact factor: 26.132

9.  Herpes simplex encephalitis presenting with exclusively frontal lobe involvement.

Authors:  Sean W Taylor; Donald H Lee; Alan C Jackson
Journal:  J Neurovirol       Date:  2007-10       Impact factor: 2.643

Review 10.  HSV encephalitis in a child with brain stem glioma: a rare complication of therapy. Case report and review of the neurosurgical literature.

Authors:  Barbara Spacca; Conor Mallucci; Andrew Riordan; Richard Appleton; Nicky Thorp; Barry Pizer
Journal:  Childs Nerv Syst       Date:  2007-06-26       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.